Abstract
The HCV genome is highly heterogeneous; more and more genotypes, each with several distinct subtypes, are being identified around the world. Knowledge of genotype is important for planning of treatment regimes, whereas subtype identification is useful in epidemiological studies and outbreak investigation. We describe HCV genotyping and subtyping assays, based on real-time PCR, that are sensitive, specific, and reliable. These assays provide fast, accurate, and convenient methods for HCV genotyping/subtyping to support clinical practice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustqi, V. K., Shiffman, M., Reindollar, R., et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958–965.
Fried, M. W., Shiffman, N. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., et al. (2002) Peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection. N. Eng. J. Med. 347, 975–982.
Lee, S., Heathcote, E., Reddy, K., Zeuzem, S., Fried, M. W., Wright, T. L., et al. (2002) Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a. J. Hepatol. 37, 500–506.
Lee, S. S. and Abdo, A. A. (2003) Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon? J. Antimicrob. Chemoth. 51, 487–491.
Hadziyannis, S. J., Sette, H., Jr., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., et al. (2004) Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomised study of treatment duration and ribavirin dose. Ann. Intern. Med. 140, 346–355.
National Institute of Clinical Excellence (NICE) guidelines (2004) Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. Technology Appraisal Guidance 75. Available at www.nice.org.uk.
NICE guidelines (2006) Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. Technology Appraisal Guidance 106. Available at http://www.nice.org.uk.
Strader, D. B., Wright, T., Thomas, D. L., and Seeff, L. B. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39, 1147–1171.
Zein, N. N. (2000) Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 13, 223–235.
Maertens, G., and Stuyver, L. (1997) Genotypes and genetic variation of hepatitis, in The Molecular Medicine of Viral Hepatitis (Harrison, T. J. and Zuckerman, A., eds.), John Wiley and Sons, Chichester, England, pp. 183–233.
Takada, N., Takase, S., Takada, A., and Date, T. (1993) Differences in the hepatitis C virus genotypes in different countries. J. Hepatol. 17, 277–283.
Xu, L.-Z., Larzul, D., Delaporte, E., Bréchot, C., and Kremsdorf, D. (1994) Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J. Gen. Virol. 75, 2393–2398.
Chamberlain, R. W., Adams, N., Saeed, A. A., Simmonds, P., and Elliott, R. M. (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J. Gen. Virol. 78, 1341–1347.
Bullock, G. C., Bruns, D.E., and Haverstick, D.M. (2002) Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin. Chem. 48, 2147–2154.
Schröter, M., Zöllner, B., Schäfer, P., Landt, O., Lass, U., Laufs, R., et al. (2002) Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J. Clin. Microbiol. 40, 246–250.
Lindh, M. and Hannoun, C. (2005) Genotyping of hepatitis C virus by Taqman real-time PCR. J. Clin. Virol. 34, 108–114.
Rolfe, K. J., Alexander, G. J. M., Wreghitt, T. G., Parmar, S., Jalal, H., and Curran, M. D. (2005) A real-time Taqman method for hepatitis C virus genotyping. J. Clin. Virol. 34, 115–121.
Chen, Z. and Weck, K. E. (2002) Hepatitis C genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40, 127–134
Sandres-Sauné, K., Deny, P., Pasquier, C., Thibaut, C., Duverlie, G., and Izopet, J. (2003) Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J. Virol. Methods 109, 187–193.
Othman, S. B., Trabelsi, A., Monnet, A., Bouzgarrou, N., Grattard, F., Beyou, A., Bourlet, T., and Pozzetto, B. (2004) Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J. Virol. Methods 119, 177–181.
Amoroso, P., Rapicetta, M., Tosti, M. E., Mele, A., Spada, E., Buonocore, S., Lettieri, G., Pierri, P., Chionne, P., Ciccaglione, A. R., and Sagliocca, L. (1998) Correlation between virus genotype and chronicity rate in acute hepatitis C. J. Hepatol. 28, 939–944.
Nakano, I., Fukuda, Y., Katano, Y., Toyoda, H., Hayashi, K., Kumada, T., and Nakano, S. (2001) Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity. J. Med. Virol. 65, 45–51.
Wiese, M., Grungreiff, K., Guthoff, W., Lafrenz, M., Oesen, U. and Porst, H. (2005) Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study. J. Hepatol. 43, 590–598.
Manesis, E. K., Papaioannou, C., Gioustozi, A., Kafiri, G., Koskinas, J., and Hadziyannis, S. J. (1997) Biochemical and virological outcome of patients with chronic hepatitis C treated with Interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Hepatology 26, 734–739.
Nakano, I., Fukuda, Y., Katano, Y., Toyoda, H., Hayashi, K., Kumada, T., and Nakano, S. (2001) Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut 49, 263–267.
Garson, J. A., Ring, C., Tuke, P., and Tedder, R. S. (1990) Enhanced detection by PCR of hepatitis C virus RNA. Lancet 336, 878–879.
Okamoto, H., Okada, S., and Sugiyama, Y. F. (1990) Detection of hepatitis C virus RNA by a two stage polymerase chain reaction with two pairs of primers from the 3′ non-coding region. Jpn. J. Exp. Med. 60, 215–222.
Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962–973.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rolfe, K.J., Wreghitt, T.G., Alexander, G.J.M., Curran, M.D. (2009). A Real-Time Taqman® Method for Hepatitis C Virus Genotyping and Methods for Further Subtyping of Isolates. In: Tang, H. (eds) Hepatitis C. Methods in Molecular Biology™, vol 510. Humana Press. https://doi.org/10.1007/978-1-59745-394-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-394-3_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-970-3
Online ISBN: 978-1-59745-394-3
eBook Packages: Springer Protocols